Falchi, L., Baron, J. M., Orlikowski, C. A. and Ferrajoli, A. (2016) “BCR SIGNALING INHIBITORS: AN OVERVIEW OF TOXICITIES ASSOCIATED WITH IBRUTINIB AND IDELALISIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA”, Mediterranean Journal of Hematology and Infectious Diseases, 80, p. e2016011. doi: 10.4084/mjhid.2016.011.